Background: Emotions may be important in patients' decisions to seek medical help for symptoms suggestive of cancer.
INTRODUCTION
Diagnosis of cancer at an early, localised stage is important to improve survival rates [1] [2] [3] . Most types of cancer are more often detected through patient presentation with symptoms rather than via screening programmes, and therefore timely help-seeking for symptoms suggestive of cancer is vital to improve patient outcomes [4] . We therefore need to improve our understanding of patients' decisions to seek medical advice for symptoms suggestive of cancer and of factors associated with the time to presentation (TTP). We define TTP as the period of time between an individual's first detection of a change in their body and the first consultation with a healthcare professional. This time interval has previously been described as 'patient delay' [5] , but the Aarhus Statement [6] recently recommended that this term should be replaced by TTP as 'delay' indicates that patients waited to seek help, whereas some consult immediately after noticing symptoms [7] . Various factors such as demographics (e.g. age) and clinical factors (e.g. symptom type) have been shown to affect TTP [8, 9] . However, an individual's appraisal of a symptom and their subsequent help-seeking behaviour are also based on individual decision-making, which is informed by symptom interpretation [10, 11] and an individual's knowledge of cancer [12] , and possibly emotions [13, 14] . The role of emotions seems less straightforward than that of cognitions: various studies have suggested that emotions such as fear are a barrier to seeking help [9, 15, 16] , whereas others have indicated that emotions could promote prompt help-seeking for cancer symptoms [17, 18] . A previous systematic review of 15 studies explored the impact of fear on 'delay' in help-seeking for symptoms of cancer and myocardial infarction [19] . The authors concluded that emotions (worry, fear and death anxiety / panic), defined by the reviewers as 'different intensities of fear', had contradicting roles in TTP [19] . In a narrative review, including qualitative studies, Facione [20] reported a list of various specific fears in relation to the discovery of breast symptoms (e.g. fear of chemotherapy, or fear of illness), and showed that different specific fears had different effects on TTP for breast cancer. The reasons for why and how specific fears may trigger or inhibit help-seeking for symptoms have not been studied [20] . In a qualitative synthesis by Smith and colleagues [9] , a fear of cancer and a fear of embarrassment (including the fear of being labelled as a time-waster and embarrassment about sensitive bodily areas), were identified as main barriers to seeking help for symptoms of various cancer types [9] . Like the other reviews, this review only identified emotions labelled as fear as playing a role in TTP with symptoms of cancer, but does show the potential relevance of other emotions (e.g. embarrassment). Previous literature reviews have not explored the contradictory role of fear or the role of other emotions on TTP. The inclusion of qualitative studies in the previous reviews limits the generalisation of conclusions regarding the impact of emotions on TTP. Furthermore, there has been little exploration of similarities and differences between populations and cancers. The aim of this systematic literature review was to examine the worldwide quantitative literature to explore how emotional factors influence patients' help-seeking for symptoms possibly suggestive of cancer. We were particularly interested in how, and to what extent, emotions contribute to TTP. The objectives were to identify: (1) which types of emotions influence help-seeking behaviour; (2) whether these form a barrier or trigger for seeking medical help; and (3) how the role of emotions varies between different cancers and populations.
METHODS
We systematically searched the databases PubMed, PsychINFO, IBSS and ASSIA up to 30 th September 2013, with no earliest year of publication or language restrictions. Reference lists of all included papers were searched, and all lead authors from publications after 2000 were contacted for further research findings (of which the latter did not lead to any further relevant papers). Search terms were focused on four main themes: emotion(s), help-seeking, cancer and symptoms, see Figure 1 . There is a surprisingly broad range of definitions of what constitutes an emotion [21] . For this review we considered the following definition the most relevant: emotion is a 'response to a certain event, which can be external or internal to the individual' [14] . We have only considered patients' subjective experiences of emotion as relevant (omitting facial expressions and physiological changes [22] ). The search terms for emotion included synonyms for emotion as well as a wide range of emotions, and we selected emotions for inclusion based on emotions listed in Scherer's affect categories [22] . These categories were based on emotions reported by people who were asked which emotions they had experienced the day before, as well as emotions measured in published emotion measures and included positive as well as negative emotions [22] . An example of an affect category is anxiety, which included 'anguish*, anxi*, apprehens*, diffiden*, jitter*, nervous*, trepida*, wari*, wary, worried*, worry*'. We included relevant emotions after reaching mutual consensus on inclusion between the authors, and we validated our selection with an international expert on early detection of cancer. We differentiated between emotion constructs (e.g. fear, anxiety and worry as separate constructs) to be able to explore their individual impact on help-seeking, and looked at a wider range of emotions and at specific emotions. We included original research papers published in peer-reviewed journals, which examined any emotion specific to symptom appraisal or help-seeking for symptoms of cancer (all types) or symptoms potentially indicative of cancer. Manuscripts were excluded if they were non peer-reviewed, conference abstracts, reviews, or reported studies with participants previously diagnosed with the same type of cancer, studies on screening, or set among nonsymptomatic individuals. *** Insert Figure 1 about here (or as supplementary file online)*** Data extraction was undertaken by all authors. Extracted data included demographics of the study sample, the definitions of included emotion and TTP, and data related to TTP. We also extracted data concerning whether the emotion was a barrier or a trigger, and how the emotion affected TTP. We chose to use a descriptive, narrative approach [23] to synthesise the papers because of the heterogeneity of study methods. For instance, there was a lack of definition or consistent use of emotion terms (for example fear was 'fear of treatment' in one study and 'fear of cancer' in another).
Quality assessment
Each author used the Dixon-Woods criteria to rate the overall relevance of each included paper as: Key Paper, Satisfactory paper, Unsure, Fatally Flawed (indicating mistakes or contradictions in results), and Irrelevant [24] . This approach was chosen based on Malpass et al's recent critique of approaches to quality assessment [25] .'Key' and 'Satisfactory' papers were included. 'Unsure' papers were discussed until we reached agreement, and papers judged 'Fatally Flawed' and 'Irrelevant' were excluded, as it was not possible to make valid or relevant conclusions from these papers. This assessment of the relevance of the data on emotion and TTP in the paper was important in our review. Rather than focusing solely on the overall quality of the paper using the guidelines such as the Critical Appraisal Skills Programme (CASP) [26, 27] , we chose to be inclusive, to be able to thoroughly review all the
RESULTS
From the initial 13,191 unique abstracts identified via the systematic search, 33 papers were included in the review (see Figure 2 for the PRISMA flow diagram). One paper was excluded based on the Dixon-Woods criteria (fatally flawed) as results in text and tables were contradictory [28] , and two included papers were rated as a key paper as their results were highly relevant [29, 30] ; the remaining studies were considered to be satisfactory. Figure 2 about here***
***Insert

Study and participant characteristics
Details of the 33 included papers can be found in Table 5 for a summary). There were two main strategies for measuring emotions. Either qualitative data was collected from participants through open questions, which were then quantified and grouped into an emotion category as defined by the researcher, or the selection of a certain emotion was decided prior to the study and measured using a questionnaire. Meechan and colleagues [29] developed a four-item measure for emotional responses to a cancer symptom. Two other studies [48, 49] used an adapted version of this measure. In measuring TTP, 19 studies adopted cut-off points indicating 'long TTP', which ranged from one week to three months. The most common cut-off was three months, but in ten papers authors used a different approach [16, 33, 36 
Range and types of emotions reported in the studies
None of the studies provided definitions of the emotions that they reported, and some used emotion terms interchangeably, for instance, in three studies worry was used interchangeably with concern [17, 45, 57]. Twenty-six studies studied fear (or closely related emotions such as being scared, afraid or having had a frightening experience) in relation to TTP, see [34, 41] . In other studies more detailed information about the emotion was given, being more specific about the reason for the emotion. These 'specific emotions' (as previously defined by Table 2 ) The proportion of patients who cited fear as a reason for not presenting earlier was generally low (below 30%), with the exception of 3 studies on breast cancer: Other emotions (see Table 4 ) Being embarrassed at being examined by a doctor was reported as a reason for later presentation by 13% of British patients with breast symptoms with long TTP (> 3 months), whereas none of the patients with short TTP reported this barrier [56] . Non-specific embarrassment was a cited as a reason for not presenting earlier for 4% of those with short TTP and 16-25% of those with long TTP (or those who were 'reluctant' to see a doctor) [34, 41] . No papers used uni/multivariate statistics to study the impact of embarrassment on TTP. Shame was a reason for later presentation for only 4.5% of the total sample in a study of breast cancer among Libyan women [51] but this was not investigated in relation to TTP. In a study on breast cancer in Ireland, levels of distress, depression, and anger on discovery of breast symptoms were found to be low (reported by less than 20% of patients) and were unrelated to TTP [48] . Two studies looked at a general emotional response to symptom discovery that consisted of the combined level of a range of non-specific emotions (e.g. afraid, anxious, distress, scared, concerned) in response to either discovering symptoms of breast cancer [29] or potentially malignant oral symptoms [49] . This general emotional response to symptom discovery was not associated with TTP in the study on oral cancer [49] but higher emotional response was associated with shorter TTP in in the study on breast cancer [29] . However, when the levels of emotional response were compared between those who sought help promptly (<3 months) and those who waited (> 3months) no significant differences were found. There appeared to be no differences for the role of emotions in TTP between age groups. For instance, the results from a study among elderly women [43] corroborated with the findings from a similar study set among younger women [44] . One study specifically investigated significant differences in reporting of being afraid of diagnosis as a barrier between the age groups <60, 60-74 and 75+, and found no significant differences [55] . No studies reported differences between sexes. No differences were found between the findings from pre-and post-diagnosis studies. Differences between cancer types were rarely explored within the studies as only 3 of the 33 papers studied more than one cancer type. Mor [40] reported the percentages of participants that gave fear of discovering the cause of their symptoms as their reason for later presentation specifically for breast (20.7%), lung (10.5%) and colorectal cancer (16.9%), but did not compare the cancer types using statistical tests. Coates and colleagues tested the association of worry / concern with TTP in patients diagnosed with breast cancer [45] and uterus cancer [57] . In both studies worry and thinking it was serious was associated with timely consultation, however worry and thinking it was cancer was only associated with short TTP among the breast cancer patients [45] . There were no differences between ethnicities in Coates et al.'s studies [45, 57] , but Talcott reported that fear was more often a reason to present late with prostate symptoms for African American men (11.1%) compared to Caucasian men (7.4%, p<0.01) [33] . Comparing cancer and non-cancer patients, fear of a cancer diagnosis was more often a reason for later presentation for patients who received a cancer diagnosis (11.5%) than patients whose diagnosis was benign (4%), including when only individuals with long TTP were considered (cancer 22.2% vs non-cancer 5.1%, X 2 = 10.8, p=.001) [47] . In a multivariate analysis by Li et al. [30] low fear on symptom discovery was related to longer appraisal interval and total TTP in the benign sample but not in the cancer sample. In contrast, low fear on symptom discovery and high fear of implications (possibly cancer) was related to a longer utilisation interval in the cancer sample, but not the benign sample [30] .
The role of emotions between different cancers and populations
CONCLUSIONS
Principal findings
This is the first systematic literature review of quantitative evidence examining the role of a wide range of emotions in TTP for potential cancer symptoms. The review provides someseemingly contradictory -evidence for a role for emotions in TTP. A key finding was that few studies had their main focus on emotions. Furthermore, there are several methodological and conceptual limitations, which limit the interpretation of the existing literature. Nevertheless, we believe that the findings provide some evidence for the impact of a range of non-specific and specific emotions on TTP for symptoms suggestive of cancer. Although we purposely looked for a wide range of emotions, we only found studies reporting a limited range of emotions, mainly related to fear and worry. Whilst these emotions may have been chosen for investigation because of their known and anticipated impact on individuals' help-seeking decisions, this does not necessarily reflect the actual range and importance of emotions that affect peoples' decisions to seek help. Other emotions could be important too: three studies indicated embarrassment may be a reason for long TTP, but at present only descriptive quantitative data (and some qualitative data [9, 61, 62]) exist. There are other emotions such as guilt [63] that may play a role in help-seeking for symptoms but have not been studied quantitatively in this context. The impact of emotions appears mixed, sometimes acting as a barrier to consultation whilst at other times being a trigger to presentation or being unrelated to TTP. Consideration of theoretical explanations of help-seeking behaviour may help to explain these inconclusive findings . Only one study [30] in the review deliberately divided between two intervals of TTP ('appraisal delay' and 'utilisation delay', which are roughly equivalent to the appraisal and help-seeking interval). This study indicated that higher fear on symptom discovery was associated with shorter appraisal delay (for the benign sample, but not for the cancer sample) and shorter utilisation delay (in the cancer sample, but not in the benign sample). A different specific fear (fear of implications of the possibility of cancer) was associated with a longer utilisation delay but unrelated to appraisal delay. This indicates that it is plausible that different emotions could play different roles at different times prior to presentation with a HCP. It also shows the importance of taking possible differences in the role of emotions in TTP between populations and contexts into account. Although none of the other studies measured emotions specifically associated within the appraisal interval or help-seeking interval per se, a number of studies reported emotions about symptoms or in response to the discovery of symptoms. Generally, worry or anxiety about or upon discovering symptoms was reported to be a reason for consulting a HCP, and was associated with shorter TTP. Fear on discovery of symptoms appeared to have contradictory impact: some studies found no effect whereas others reported this emotion to be associated with shorter TTP. Regarding the help-seeking interval, fears that were about seeking help, diagnosis, treatment and its consequences were generally barriers to seeking help [43, 47] 
Strengths and limitations of the review
Strengths of our review were the systematic search of literature including a wide range of emotions and that initially identified 13,180 papers in four databases, and rigorous data extraction conducted by three authors from complementary disciplines (medicine, psychology and social science). We could not perform a meta-analysis of the study results, as there was a lack of consensus on emotion definitions and study methods. Meta-analysis could have provided more insights into the actual impact of emotions on TTP, and could have provided information on the size of the effect of emotions in TTP. However, a descriptive synthesis of the heterogeneous studies allowed exploration of the possibility of different effects of different specific emotions on TTP.
Methodological issues in existing research
We have identified various methodological limitations of the included studies. Firstly, very few of the studies had emotion as the main focus of the research. In fact, only two studies stated the aim to explore the relationship between emotion and TTP, Bradley [42] and Li, Lam [30] formulated specific hypotheses. Secondly, there was little homogeneity in the way emotions were defined and measured in the studies. This makes it difficult to evaluate their construct validity and to compare seemingly similar emotions between studies. The conflicting results around the role of emotions on TTP may be due to the lack of definition of each specific emotion. Closely related to this is that none of the studies have used validated questionnaires -an issue considered important in researching TTP according to the Aarhus statement [6] . This means that it is not possible to know if the emotions measured were actually reflecting these specific emotions, and to which extent the results were comparable across studies. Thirdly, studies tended to explore 'reasons for later presentation' rather than focusing on exploring all possible directions of the relationship between TTP and emotion [65] . This aspect of study design led many studies to only study emotions in those who waited prior to seeking help, omitting the potential role of emotions in reducing TTP. Furthermore, as with all research into help-seeking the majority of the studies are retrospective, with some studies including patients who had been diagnosed with cancer for many months or years. It is likely that this may have biased their recall of emotions during the TTP with their symptoms. This recall bias may also differ between patients diagnosed with cancer and people who were still awaiting their diagnosis at the time they participated in the study, or those diagnosed with a benign condition. Finally, few studies focused on the = size of the impact of the emotion(s) on TTP, and with the current knowledge in this review, we cannot be sure how important it is to look at the role of patients' emotions in help-seeking decisions: a difference in TTP of 1 day is likely not to be clinically relevant, but a difference of 2 weeks or more might be.
Implications
There is a need for further well-designed studies guided by the Aarhus statement [6], including clear definitions of specific emotions as well as non-specific emotions to identify the patient groups at risk for later presentation and the impact of emotions which may increase or decrease this risk. This may help in the development of relevant interventions targeting these patient groups and specific emotions, and emotions associated with symptom appraisal or help-seeking and its consequences. Exploring the link between cognitions and emotions as suggested in the Common-Sense Model by Leventhal [13] could unpack the role of emotions in symptom appraisal, and more specifically the concept of symptoms being 'worrisome'. Qualitative studies could also improve our understanding of why, and under which circumstances, emotions play a role in people's decisions to seek help for symptoms suggestive of cancer. It will also be important to take differences between populations, settings, cancers and symptoms into account in future studies. For example, fear of treatment may have a more negative impact on TTP if the treatment is perceived as particularly harmful, for example in a country where radical mastectomy is the most common treatment for breast cancer compared with a lumpectomy as the most common choice in other countries. As the majority of the studies in this review researched breast cancer, future research could also include other cancer types which are equally common among the population and causing higher mortality, such as colorectal cancer and lung cancer [66] .
Conclusion
This systematic review provides some quantitative evidence for the role of emotions as barriers as well as triggers in TTP, and suggests a role for a wider range of emotions including specific emotions. However, it also highlighted widespread methodological, definition and design issues among the included papers, therefore more quantitative welldesigned research is needed to be able to draw stronger conclusions on the different roles of specific emotions in the pathway to presentation for potential cancer symptoms. 
